|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 11.91 SEK | +0.59% |
|
+6.34% | -43.82% |
| 11-13 | Saniona Gets Positive EU Orphan Drug Opinion for Neurodevelopmental Disorder Treatment | MT |
| 11-13 | Saniona receives positive EMA opinion on orphan designation for SAN2668 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- SANION Stock
- Charts SANA AB
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
